<DOC>
	<DOCNO>NCT01107782</DOCNO>
	<brief_summary>The purpose study determine whether sildenafil effective safe treatment fetal growth restriction .</brief_summary>
	<brief_title>Sildenafil Uteroplacental Perfusion</brief_title>
	<detailed_description>Fetal growth retardation affect 8 % pregnancy massive short term ( increased fetal morbidity mortality ) long-term ( increased incidence cardiovascular disorder adulthood ) health implication . Doppler waveform analysis pregnancy suggest compromised uteroplacental circulation placental hypoperfusion . Our aim ass sildenafil citrate could improve vasodilatation FGR pregnancy . Sildenafil citrate may offer potential therapeutic strategy improve uteroplacental perfusion FGR . Animal study suggest phosphodiesterase-5 ( PDE5 ) inhibitor , sildenafil citrate , may improve uterine blood flow .</detailed_description>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>FGR pregnancy 2437 week GA vasodilator agent usage history cardiovascular morbidity specially right heart side drug alcohol abuser systolic BP 210 mm Hg diastolic BP 120 mm Hg</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>sildenafil</keyword>
	<keyword>FGR</keyword>
</DOC>